Your browser doesn't support javascript.
loading
Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study.
Wray, Sibyl; Hayward, Brooke; Dangond, Fernando; Singer, Barry.
Affiliation
  • Wray S; a Hope Neurology Multiple Sclerosis Center , Knoxville , TN , USA.
  • Hayward B; b EMD Serono, Inc ., Billerica , MA , USA.
  • Dangond F; b EMD Serono, Inc ., Billerica , MA , USA.
  • Singer B; c The MS Center for Innovations in Care, Missouri Baptist Medical Center , St. Louis , MO , USA.
Expert Opin Drug Deliv ; 15(2): 127-135, 2018 02.
Article in En | MEDLINE | ID: mdl-29206056

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adjuvants, Immunologic / Patient Satisfaction / Multiple Sclerosis, Relapsing-Remitting / Patient Preference / Interferon beta-1a / Injections, Subcutaneous Type of study: Clinical_trials / Guideline / Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Expert Opin Drug Deliv Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2018 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adjuvants, Immunologic / Patient Satisfaction / Multiple Sclerosis, Relapsing-Remitting / Patient Preference / Interferon beta-1a / Injections, Subcutaneous Type of study: Clinical_trials / Guideline / Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Expert Opin Drug Deliv Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2018 Document type: Article Affiliation country: United States Country of publication: United kingdom